Endoscopic Endonasal Surgery Treatment Strategies for Invasive Pituitary Adenoma: Analysis of Four Approaches

医学 外科 垂体腺瘤 神经外科 鼻内镜手术 垂体机能减退 治愈率 内窥镜检查 阶段(地层学) 腺瘤 内科学 颅骨 生物 古生物学
作者
Yang Ji-Hu,Huang Guo-dong,Ji Tao,Wang Hai-Dong,Liu Yu-fei,Guo Jian,Li Zhen,Li Wei-Ping
出处
期刊:World Neurosurgery [Elsevier]
被引量:8
标识
DOI:10.1016/j.wneu.2018.02.162
摘要

To explore the surgical methods and clinical effect of endoscopic endonasal approaches for the treatment of invasive pituitary adenomas (IPAs).A retrospective analysis was made of the clinical data of 74 patients (75 procedures) with IPAs treated by different endoscopic endonasal approaches at the Department of Neurosurgery, The First Affiliated Hospital of Shenzhen University from May 2014 to August 2017. The data include clinical manifestation, imaging features, surgical methods and complications, resection rate, cure rate, prognosis, and complications in different Knosp classifications and Hardy stages. The transcavernous approach was used in 47 patients, the lateral-cavernous approach was used in 14 patients, the tuberculum sella planum approach was used in 8 patients, and the diaphragma sellae open or dorsum sellae cut approach was used in 6 patients.The gross total resection (GTR) rate was 70.7% (53 patients) and tumor residue rate was 29.3% (22 patients). GTR rate for pituitary adenoma according to Knosp classification was 89.3% in grade 3 and 28.6% in grade 4. The biology cure rate was 75.0% and 23.8%, respectively. There was significance between them (P < 0.05). In addition, the GTR rate of Hardy stage was 90.5% in stage C, 90.0% in stage D, 26.1% in stage E, and the biology cure rate was 80.1%, 75.0%, and 13.0%, respectively. There was significance among them (P < 0.05) Postoperative severe complications included 9 patients (12.0%) with cerebrospinal fluid leaks, 26 patients (34.7%)with electrolyte imbalance, 36 patients (48.0%) with transient diabetes insipidus, 22 patients (29.3%) with hypopituitarism, 2 patients (2.7%) with permanent hypopituitarism, and 2 patients (2.7%)with epistaxis. The follow-up lasted 2-41 months (average, 19.3 months). No patient experienced recurrence after GTR, 1 patient undergoing subtotal experienced recurrence and underwent reoperation, 3 patients underwent postoperative Gamma Knife treatment, and 2 patients with refractory IPA were given temozolomide and metformin chemotherapy.According to the invasiveness of IPA, choosing the appropriate endoscopic surgical approach is helpful in removing tumors and reducing complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
浮游应助科研通管家采纳,获得10
刚刚
小哦嘿应助科研通管家采纳,获得10
刚刚
科研通AI6应助科研通管家采纳,获得10
1秒前
科研通AI6应助科研通管家采纳,获得10
1秒前
深情安青应助科研通管家采纳,获得10
1秒前
Hhh完成签到,获得积分10
1秒前
NexusExplorer应助科研通管家采纳,获得30
1秒前
eon发布了新的文献求助20
1秒前
无花果应助科研通管家采纳,获得10
1秒前
浮游应助科研通管家采纳,获得10
1秒前
小哦嘿应助科研通管家采纳,获得10
2秒前
2秒前
科研通AI6应助科研通管家采纳,获得10
2秒前
orixero应助科研通管家采纳,获得10
2秒前
2秒前
平贝花应助科研通管家采纳,获得10
2秒前
2秒前
小哦嘿应助科研通管家采纳,获得10
2秒前
浮游应助科研通管家采纳,获得10
2秒前
脑洞疼应助科研通管家采纳,获得10
3秒前
浮游应助科研通管家采纳,获得10
3秒前
平贝花应助科研通管家采纳,获得10
3秒前
小马甲应助科研通管家采纳,获得10
3秒前
cc应助科研通管家采纳,获得30
3秒前
科研通AI6应助科研通管家采纳,获得20
3秒前
天天快乐应助科研通管家采纳,获得10
3秒前
共享精神应助缥缈傥采纳,获得10
4秒前
李爱国应助科研通管家采纳,获得10
4秒前
CipherSage应助科研通管家采纳,获得10
4秒前
菌子锅发布了新的文献求助10
4秒前
浮游应助科研通管家采纳,获得10
4秒前
乐乐应助科研通管家采纳,获得10
4秒前
慕青应助科研通管家采纳,获得10
4秒前
4秒前
4秒前
走走发布了新的文献求助10
5秒前
8秒前
跳跃的血茗完成签到 ,获得积分10
8秒前
bkagyin应助棋士采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 9000
Encyclopedia of the Human Brain Second Edition 8000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Real World Research, 5th Edition 680
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5685045
求助须知:如何正确求助?哪些是违规求助? 5040038
关于积分的说明 15185849
捐赠科研通 4844104
什么是DOI,文献DOI怎么找? 2597110
邀请新用户注册赠送积分活动 1549690
关于科研通互助平台的介绍 1508176